Ceribell Inc. has set ambitious revenue targets of $85-88 million for 2025, driven by strong financial performance and expansion into new market segments.

Ceribell Inc’s stock price has plummeted from a 52-week high of $32.74 to a 52-week low of $10.01, raising concerns about investor confidence and the company’s ability to compete in the highly competitive health care sector.